Med-tech firms raising money in public or private financings, including: Dassault Systèmes, Click Therapeutics, Iridex, Medidata, Sequana.

Visen Pharmaceuticals Co. Ltd. announced its initial public offering (IPO) on the Hong Kong Stock exchange (HKEX) to raise roughly HKD$603.3 million (US$77.6 million) to advance its pipeline of endocrinology assets.

Biopharmas raising money in public or private financings, including: Arch Biopartners, Chance, Curevo, Latigo.

Leading pharma companies have pitched into Sofinnova Partners’ new accelerator fund, which has exceeded the target and closed at €165 million (US$180 million). In what is said to be the largest pan-European biotech accelerator fund, Amgen Inc., Bristol Myers Squibb Co. and Pfizer Ventures will get an inside track on startups formed around academic research, as the nascent companies are shaped up for formal investment rounds.

Med-tech firms raising money in public or private financings, including: Insulet, Madison Scientific.

Biopharmas in Asia-Pacific raising money in public or private financings: Accropeutics.

Maxion Therapeutics Ltd. is poised to extend the therapeutic reach of antibodies into the vast field of G-protein coupled receptors and ion channel targets, after raising $72 million in a series A round.

Biopharmas raising money in public or private financings, including: Accropeutics, Galderma.